GlassScriptPhysician profile
Lisa Mcdivitt
NPI 1013440908
$186.55
in general payments reported to CMS, 2019-2025
9 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $44.72 · 2022: $81.03 · 2023: $16.42 · 2024: $44.38.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $60.80.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $60.80 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Takeda Pharmaceuticals U.S.A., INC. | $59.18 | 2021-2022 | |
| Pfizer INC. | $27.33 | 2024 | |
| Sanofi-Aventis U.S. LLC | $17.05 | 2024 | |
| Merck Sharp & Dohme LLC | $16.42 | 2023 | M-M-R II, Vaxelis, Gardasil 9 |
| Tris Pharma INC | $15.10 | 2021 | |
| Kaleo, INC. | $14.28 | 2022 | |
| Allegis Pharmaceuticals, LLC | $13.38 | 2022 | |
| Sanofi Pasteur INC. | $11.92 | 2022 | |
| Glaxosmithkline, LLC. | $11.89 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Lisa Mcdivitt listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.